Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH / E. Gasparini, M. Ragazzi, A. Bisagni, E. Kuhn, C. Bassano, I. Tamagnini, M. Foroni, G. Falco, G. Ferrari, L. Braglia, L. Savoldi, A. Bologna, R. di Cicilia, G. Gardini, G. Bisagni. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 1527-7755. - 35:15(2017 May 20), pp. 1028.1-1028.1. (Intervento presentato al 53. convegno Annual Clinical Science Meeting of the American Society of Clinical Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET : June, 02-07 tenutosi a Chicago (ILL, USA) nel 2017) [10.1200/JCO.2017.35.15_SUPPL.1028].
Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH
E. Kuhn;
2017
| File | Dimensione | Formato | |
|---|---|---|---|
|
Impact of 2013 ASCO_CAP guidelines on HER2 determination of invasive breast cancer_ A single institution experience using frontline dual-color FISH. _ Journal of Clinical Oncology.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
323.1 kB
Formato
Adobe PDF
|
323.1 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
